Updated AUA/SUO Advanced Prostate Cancer guideline emphasizes role of PSMA-PET

In this interview, Kristen R. Scarpato, MD, MPH, discusses 2026 American Urological Association (AUA)/Society of Urologic Oncology (SUO) Advanced Prostate Cancer Guideline amendment recommendations regarding the role of prostate-specific membrane antigen (PSMA)-PET imaging across the prostate cancer continuum, highlighting its impact on disease detection, treatment decision-making, and ongoing questions surrounding its clinical implications.¹ Scarpato is an associate professor of urology at Vanderbilt University Medical Center in Nashville, Tennessee.